Defense Secretary, ex-chairman of flu treatment rights holder, sees portfolio value growing.
NEW YORK (Fortune) - The prospect of a bird flu outbreak may be panicking people around the globe, but it's proving to be very good news for Defense Secretary Donald Rumsfeld and other politically connected investors in Gilead Sciences, the California biotech company that owns the rights to Tamiflu, the influenza remedy that's now the most-sought after drug in the world.
Lees verder bij CNN
Geen opmerkingen:
Een reactie posten